{
  "hypothesis": "h247",
  "title": "Disease-Specific Biologic Routing",
  "outcome": "VALIDATED",
  "summary": {
    "baseline_precision": 5.9,
    "broad_filtering": {
      "description": "All known biologic success diseases",
      "predictions": 92,
      "precision": 13.0,
      "improvement": "+7.2 pp"
    },
    "tier1_filtering": {
      "description": "RA, PsA, melanoma, psoriasis, temporal arteritis only",
      "predictions": 23,
      "precision": 30.4,
      "improvement": "+24.5 pp",
      "success_criteria": "PASS (>25%)"
    },
    "mechanism_matching": {
      "description": "Drug mechanism matches disease indication",
      "predictions": 17,
      "precision": 64.7,
      "improvement": "+58.8 pp",
      "success_criteria": "PASS (>25%)"
    }
  },
  "mechanism_matching_rules": {
    "adalimumab": [
      "rheumatoid",
      "psoria",
      "crohn",
      "colitis",
      "ankylosing"
    ],
    "infliximab": [
      "rheumatoid",
      "psoria",
      "crohn",
      "colitis",
      "ankylosing"
    ],
    "etanercept": [
      "rheumatoid",
      "psoria",
      "ankylosing"
    ],
    "tocilizumab": [
      "rheumatoid",
      "juvenile idiopathic",
      "temporal arteritis",
      "giant cell"
    ],
    "rituximab": [
      "rheumatoid",
      "vasculitis",
      "pemphigus",
      "lupus"
    ],
    "secukinumab": [
      "psoria",
      "ankylosing"
    ],
    "tofacitinib": [
      "rheumatoid",
      "psoria",
      "colitis",
      "crohn"
    ],
    "baricitinib": [
      "rheumatoid",
      "dermatitis",
      "alopecia"
    ],
    "pembrolizumab": [
      "melanoma",
      "lung cancer",
      "renal",
      "head neck",
      "bladder"
    ],
    "nivolumab": [
      "melanoma",
      "lung cancer",
      "renal",
      "head neck"
    ]
  },
  "key_findings": [
    "Broad disease filtering improves from 5.9% to 13.0% but doesn't reach 25% threshold",
    "Tier 1 disease filtering (5 diseases) achieves 30.4% precision - PASSES threshold",
    "Mechanism matching achieves 64.7% precision - BEST approach for biologics",
    "11/17 mechanism-matched predictions are GT hits",
    "This transforms biologics from 'exclude' to 'high confidence when matched'"
  ],
  "recommendations": [
    "Implement mechanism-matching for biologic predictions in production",
    "Only show biologic predictions when drug mechanism matches disease indication",
    "This is a major improvement: 5.9% \u2192 64.7% precision"
  ]
}